
electroCore ECOR
$ 6.17
-0.08%
Annual report 2025
added 03-19-2026
electroCore Total Liabilities 2011-2026 | ECOR
Annual Total Liabilities electroCore
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 20.4 M | 12.9 M | 8.66 M | 7.67 M | 6.18 M | 7.87 M | 10.6 M | 7.32 M | 129 M | 61.7 M | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 129 M | 6.18 M | 27.2 M |
Quarterly Total Liabilities electroCore
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 22.5 M | 13.4 M | 11.7 M | 12.9 M | 11.6 M | 10.9 M | 9.39 M | 8.66 M | 9.07 M | 7.16 M | 6.45 M | 7.67 M | 7.29 M | - | 5.36 M | 6.18 M | 6.45 M | 6.68 M | 7.08 M | 7.87 M | 7.87 M | 7.87 M | 7.87 M | 10.6 M | 10.6 M | 10.6 M | 10.6 M | 7.32 M | 7.32 M | 7.32 M | 7.32 M | 6.43 M | 6.43 M | 6.43 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 22.5 M | 5.36 M | 8.87 M |
Total Liabilities of other stocks in the Medical instruments industry
| Issuer | Total Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
17.9 K | - | - | $ 810 M | ||
|
iRhythm Technologies
IRTC
|
867 M | $ 127.76 | 4.42 % | $ 4.09 B | ||
|
Repro Med Systems
KRMD
|
11.2 M | $ 4.07 | 2.65 % | $ 188 M | ||
|
Microbot Medical
MBOT
|
3.99 M | $ 2.17 | -1.14 % | $ 99.4 M | ||
|
Milestone Scientific
MLSS
|
4.99 M | $ 0.32 | 0.37 % | $ 26.3 M | ||
|
Luminex Corporation
LMNX
|
308 M | - | - | $ 1.75 B | ||
|
Akers Biosciences, Inc.
AKER
|
1.53 M | - | -9.52 % | $ 20.6 M | ||
|
Alcon
ALC
|
9.52 B | $ 76.16 | 0.47 % | $ 40.4 B | ||
|
Ekso Bionics Holdings
EKSO
|
11.1 M | $ 11.1 | -0.72 % | $ 26.9 M | ||
|
STERIS plc
STE
|
3.53 B | $ 222.32 | 0.23 % | $ 21.9 B | ||
|
The Cooper Companies
COO
|
4.16 B | $ 65.0 | 0.9 % | $ 12.9 B | ||
|
Teleflex Incorporated
TFX
|
3.82 B | $ 136.23 | -0.24 % | $ 6.08 B | ||
|
Antares Pharma, Inc.
ATRS
|
93.4 M | - | - | $ 955 M | ||
|
Cantel Medical Corp.
CMD
|
1.34 B | - | -1.18 % | $ 3.4 B | ||
|
CRH Medical Corporation
CRHM
|
85.8 M | - | - | $ 282 M | ||
|
Hill-Rom Holdings, Inc.
HRC
|
2.94 B | - | -0.05 % | $ 10.3 B | ||
|
Varian Medical Systems, Inc.
VAR
|
2.38 B | - | -0.02 % | $ 16.3 B | ||
|
Utah Medical Products
UTMD
|
3.27 M | $ 67.76 | 0.87 % | $ 220 M | ||
|
Haemonetics Corporation
HAE
|
680 M | $ 61.27 | 2.24 % | $ 3.08 B | ||
|
ICU Medical
ICUI
|
315 M | $ 123.83 | -0.79 % | $ 3.05 B | ||
|
Envista Holdings Corporation
NVST
|
2.62 B | $ 26.83 | 0.13 % | $ 4.51 B | ||
|
Isoray
ISR
|
59.9 M | - | 0.03 % | $ 108 M | ||
|
Intuitive Surgical
ISRG
|
2.52 B | $ 476.76 | -1.13 % | $ 170 B | ||
|
West Pharmaceutical Services
WST
|
1.09 B | $ 302.65 | -1.06 % | $ 21.9 B | ||
|
Glaukos Corporation
GKOS
|
479 M | $ 122.71 | 1.01 % | $ 5.94 B | ||
|
Masimo Corporation
MASI
|
1.57 B | $ 178.63 | - | $ 9.52 B | ||
|
InfuSystem Holdings
INFU
|
51.4 M | $ 10.83 | 4.74 % | $ 224 M | ||
|
Merit Medical Systems
MMSI
|
1.1 B | $ 67.65 | -1.36 % | $ 4 B | ||
|
Pulse Biosciences
PLSE
|
13.9 M | $ 22.81 | -0.91 % | $ 1.54 B | ||
|
DENTSPLY SIRONA
XRAY
|
4.09 B | $ 11.9 | -0.13 % | $ 2.37 B | ||
|
Retractable Technologies
RVP
|
68.3 M | $ 0.64 | -2.05 % | $ 19.2 M | ||
|
Pro-Dex
PDEX
|
24.6 M | $ 51.46 | -1.23 % | $ 169 M | ||
|
LeMaitre Vascular
LMAT
|
222 M | $ 115.76 | 2.04 % | $ 2.62 B | ||
|
Predictive Oncology
POAI
|
5.17 M | - | - | $ 31.1 M | ||
|
STAAR Surgical Company
STAA
|
107 M | $ 26.3 | 2.45 % | $ 1.3 B | ||
|
BioLife Solutions
BLFS
|
50.6 M | $ 21.55 | 0.78 % | $ 993 M | ||
|
Stereotaxis
STXS
|
33.5 M | $ 1.94 | 0.52 % | $ 176 M | ||
|
Baxter International
BAX
|
14 B | $ 18.33 | 0.91 % | $ 9.4 B | ||
|
ResMed
RMD
|
1.74 B | $ 221.76 | 0.87 % | $ 32.4 B | ||
|
AtriCure
ATRC
|
162 M | $ 29.41 | 0.43 % | $ 1.4 B | ||
|
Harvard Bioscience
HBIO
|
66.3 M | $ 6.69 | -2.48 % | $ 297 M | ||
|
NeuroMetrix
NURO
|
1.01 M | - | 5.05 % | $ 9.02 M | ||
|
AngioDynamics
ANGO
|
97.2 M | $ 11.14 | 0.36 % | $ 455 M | ||
|
Becton, Dickinson and Company
BDX
|
30.7 B | $ 151.85 | -0.18 % | $ 43.7 B | ||
|
Nephros
NEPH
|
3.5 M | $ 3.01 | 4.88 % | $ 31.3 M | ||
|
OraSure Technologies
OSUR
|
62.3 M | $ 2.99 | -0.5 % | $ 220 M | ||
|
Repligen Corporation
RGEN
|
866 M | $ 118.32 | 0.61 % | $ 6.59 M |